Evidence map›Paper›PMID 27195673›Full record

ReviewCell death & disease2016

Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.

Q Qu, F Zeng, X Liu, Q J Wang, F Deng

Open access · goldAbstract readReview
In one paragraph

Review in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 317 papers.

0numbers the graph read from it
0cells of the map it votes in
317citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

317 citing papers in PubMed, 555 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Active aldehydes accelerate CD8Nature immunology · 2026
    Article
  18. Article
  19. Article
  20. Article

257 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Q QuDepartment of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
F ZengDepartment of Clinical Laboratory, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
X LiuDepartment of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Q J WangDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
F DengDepartment of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Southern Medical University · CNUniversity of Pittsburgh · US

Funding

Development of small molecule inhibitors of protein kinase DR01CA142580 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WANG, QIMING JANE · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA142580
6 · The paper itself

Abstract

Tumor cells exhibit unique metabolic adaptations that are increasingly viewed as potential targets for novel and specific cancer therapies. Among these targets, the carnitine palmitoyltransferase system is responsible for delivering the long-chain fatty acid (FA) from cytoplasm into mitochondria for oxidation, where carnitine palmitoyltransferase I (CPTI) catalyzes the rate-limiting step of fatty acid oxidation (FAO). With increasing understanding of the crucial role had by fatty acid oxidation in cancer, CPTI has received renewed attention as a pivotal mediator in cancer metabolic mechanism. CPTI activates FAO and fuels cancer growth via ATP and NADPH production, constituting an essential part of cancer metabolism adaptation. Moreover, CPTI also functionally intertwines with other key pathways and factors to regulate gene expression and apoptosis of cancer cell. Here, we summarize recent findings and update the current understanding of FAO and CPTI in cancer and provide theoretical basis for this enzyme as an emerging potential molecular target in cancer therapeutic intervention.

Indexed as

Gene Expression Regulation, NeoplasticAdenosine TriphosphateAntineoplastic AgentsCarnitineCarnitine O-PalmitoyltransferaseCytoplasmFatty AcidsHumansIsoenzymesLipid MetabolismMitochondriaMolecular Targeted TherapyNADPNeoplasmsOxidation-ReductionAdenosine TriphosphateAntineoplastic AgentsCarnitineCarnitine O-PalmitoyltransferaseCPT1A protein, humanFatty AcidsIsoenzymesNADPST1326

Identifiers

PMID27195673
PMCPMC4917665
OpenAlexW2399064224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.